Literature DB >> 2654192

Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.

D W Rogers1, J G Treleaven, J T Kemshead, J Pritchard.   

Abstract

One hundred and sixty six bone marrow aspirates from children with abdominal neuroblastoma were independently examined for the presence of neuroblastoma cells by conventional haematological staining techniques and by indirect immunofluorescence using one or more of five monoclonal antibodies. Results using the two methods were evaluated by comparison with the results of bone marrow, bone and lymph node biopsy specimens taken at the same time, and in the light of the child's clinical course. One antibody, UJ13A, was found to have 98.5% specificity and 85.7% sensitivity, compared with sensitivities for conventional staining of 50% for aspirate alone and of aspirate or trephine biopsy specimen of 71.4%. The remaining antibodies UJ127/11, UJ223/8, UJ181/4 and UJ167/11, with specificities in the range 94-99%, were found to have sensitivities in the range 47-61%, lower than the sensitivity of conventionally stained aspirate or trephine biopsy specimen. Routine immunofluorescence staining with monoclonal antibody UJ13A should increase the sensitivity of detection of metastatic neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654192      PMCID: PMC1141916          DOI: 10.1136/jcp.42.4.422

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Detection of malignant cells in histologically normal bone marrow using culture techniques.

Authors:  S S Joshi; A Kessinger; S L Mann; M Stevenson; D D Weisenburger; W P Vaughan; J O Armitage; J G Sharp
Journal:  Bone Marrow Transplant       Date:  1987-02       Impact factor: 5.483

2.  A proposed staging for children with neuroblastoma. Children's cancer study group A.

Authors:  A E Evans; G J D'Angio; J Randolph
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

3.  Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders.

Authors:  J T Kemshead; A Goldman; J Fritschy; J S Malpas; J Pritchard
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

4.  Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children.

Authors:  M Tsokos; R I Linnoila; R S Chandra; T J Triche
Journal:  Hum Pathol       Date:  1984-06       Impact factor: 3.466

5.  Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

Authors:  E A Shafford; D W Rogers; J Pritchard
Journal:  J Clin Oncol       Date:  1984-07       Impact factor: 44.544

6.  Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues.

Authors:  P M Allan; J A Garson; E I Harper; U Asser; H B Coakham; B Brownell; J T Kemshead
Journal:  Int J Cancer       Date:  1983-05-15       Impact factor: 7.396

7.  Immunohistochemical performance testing of monoclonal antibodies to neuroblastoma cells on normal adrenals, spinal and sympathetic ganglia, and neural crest tumours.

Authors:  B R Oppedal; P Brandtzaeg; J T Kemshead
Journal:  Histopathology       Date:  1987-04       Impact factor: 5.087

8.  Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies.

Authors:  I M Franklin; J Pritchard
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

9.  High-resolution in situ hybridization technique using biotinylated NMYC oncogene probe reveals periodic structure of HSRs in human neuroblastoma.

Authors:  J A Garson; J A van den Berghe; J T Kemshead
Journal:  Cytogenet Cell Genet       Date:  1987

10.  Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.

Authors:  M C Favrot; D Frappaz; O Maritaz; I Philip; B Fontaniere; O Gentilhomme; C Bailly; J M Zucker; J C Gentet; J Kemshead
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

  10 in total
  5 in total

Review 1.  Micrometastases in neuroblastoma: are they clinically important?

Authors:  S A Burchill
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

2.  Detection of bone marrow metastases in neuroblastoma using a short term tissue culture technique.

Authors:  J A Adams; A M Kelsey; T F Carr; R F Stevens; P Morris-Jones
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

3.  Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma.

Authors:  M M Reid; J P Wallis; A G McGuckin; A D Pearson; A J Malcolm
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

4.  Immunocytochemical examination of bone marrow in disseminated neuroblastoma.

Authors:  P J Carey; L Thomas; G Buckle; M M Reid
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

5.  Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells.

Authors:  S A Burchill; I J Lewis; P Selby
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.